STOCKHOLM (dpa-AFX) - Biopharmaceutical company Cortendo has filed a
registration statement on Form F-1 with the U.S. with the SEC to raise up to
$86.25 million in an initial public offering.
The Trevose, Pennsylvania-based company's stock...
PETAH TIKVA (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) has acquired rights
to Testosterone Gel 1% product, previously licensed to Teva Pharmaceutical
Industries Ltd. (TEVA).
Upon commercialization, ANI will pay Teva up to $5 million at a rate...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol,...
Corcept Therapeutics Incorporated (NASDAQ:CORT)
Q2 2014 Results Earnings Conference Call
August 5, 2014, 05:00 PM ET
Charlie Robb – CFO
Joseph Belanoff – CEO and President
Steven Lo – VP and Chief Commercial...
CHICAGO, IL -- (Marketwired) -- 06/20/14 -- In the news release, "New Research on Corcept's Korlym® for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014," issued Thursday, June 19, 2014 by Corcept Therapeutics (NASDAQ: CORT), we...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.